Glasgow, UK 08 Oct 2024 - 10 Oct 2024
ea0103p76 | Bone 2
ea0103p77 | Bone 2
ea0103p78 | Bone 2
Safety and efficacy of long-term continuous subcutaneous PTH (1-34) infusion therapy (CSPI) for severe autosomal dominant hypocalcaemia type 1 (ADH1) in children and young people
ea0103p79 | Bone 2
ea0103p80 | Bone 2
ea0103p81 | Bone 2
ea0103p82 | Bone 2